Literature DB >> 18241257

Intravenous immunoglobulin for pyoderma gangrenosum.

A Kreuter, S Reich-Schupke, M Stücker, P Altmeyer, T Gambichler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18241257     DOI： 10.1111/j.1365-2133.2007.08433.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Refractory Peristomal Pyoderma Gangrenosum Successfully Treated With Intravenous Immunoglobulin: A Case Report.

Authors:  Brian P McAllister; Emmanuelle D Williams; Lisa J Yoo; Andrew Tinsley; Walter Koltun; Christine M Ardell; Suzi B Follett; Diane M Paskey
Journal:  Am J Gastroenterol       Date:  2015-12       Impact factor: 10.864

Review 2.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

Review 3.  [Therapeutic administration of immunoglobulins].

Authors:  T Witte
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

4.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

5.  Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature.

Authors:  John Cafardi; Naveed Sami
Journal:  Case Rep Dermatol       Date:  2014-10-23

Review 6.  Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature.

Authors:  Aleksandra Opalińska; Dominika Kwiatkowska; Adrian Burdacki; Mirosław Markiewicz; Dominik Samotij; Marek Dudziński; Jadwiga Niemiec-Dudek; Elżbieta Ostańska; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2021-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.